Literature DB >> 15257105

The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents.

Keiichi Suzuki1, Koichi Aiura, Masakazu Ueda, Masaki Kitajima.   

Abstract

OBJECTIVE: Using a chemoinvasion assay, we show that platelets promote invasiveness of 5 pancreatic adenocarcinoma cell lines.
METHODS: Gelatin zymography and Western blot analysis were performed to detect metalloproteinase-9 (MMP-9) secreted from tumor cells in the presence or absence of platelets. The effects of antiplatelet agents on the invasiveness of tumor cells and the secretion level of MMP-9 were evaluated.
RESULTS: The number of traversed tumor cells significantly increased when incubated with platelets compared without platelets in all cell lines. The MMP-9 band was detected in all tumor cell lines, and the intensity was obviously greater in conditions of incubation with platelets than without. In the experiment of antiplatelet agents effects, it was confirmed that invasiveness of tumor cells significantly decreased following incubation with cilostazol depending on the concentration in spite of the presence of platelets. The level of MMP-9 also significantly decreased in the ELISA analysis.
CONCLUSIONS: These data mean platelets activate invasiveness of tumor cells because of enhanced MMP-9 secretion. Furthermore, anti-platelet drugs may inhibit invasiveness of tumor cells due to decreased MMP-9 secretion, and this inhibition may lead to the suppression of tumor cell invasion. We propose that antiplatelet agents are applicable in clinical treatment to inhibit metastasis of malignant tumor cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257105     DOI: 10.1097/00006676-200408000-00008

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  32 in total

1.  The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-κB inhibition.

Authors:  Julie Sahler; Jamie J Bernard; Sherry L Spinelli; Neil Blumberg; Richard P Phipps
Journal:  Thromb Res       Date:  2011-01-26       Impact factor: 3.944

2.  Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients.

Authors:  Wei-wei Zhang; Ke-jun Liu; Guo-lin Hu; Wei-jiang Liang
Journal:  Tumour Biol       Date:  2015-06-11

3.  Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor.

Authors:  Kyriakos Neofytou; Elizabeth C Smyth; Alexandros Giakoustidis; Aamir Z Khan; David Cunningham; Satvinder Mudan
Journal:  Med Oncol       Date:  2014-09-14       Impact factor: 3.064

4.  The platelet NLRP3 inflammasome is upregulated in a murine model of pancreatic cancer and promotes platelet aggregation and tumor growth.

Authors:  Brian A Boone; Pranav Murthy; Jennifer L Miller-Ocuin; Xiaoyan Liang; Kira L Russell; Patricia Loughran; Meinrad Gawaz; Michael T Lotze; Herbert J Zeh; Sebastian Vogel
Journal:  Ann Hematol       Date:  2019-04-24       Impact factor: 3.673

5.  The pre-treatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and red cell distribution width predict prognosis in patients with laryngeal carcinoma.

Authors:  Medine Kara; Sema Uysal; Uğur Altinişik; Sibel Cevizci; Oğuz Güçlü; Fevzi Sefa Dereköy
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-12       Impact factor: 2.503

6.  Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis.

Authors:  C E Holmes; J E Levis; D L Ornstein
Journal:  Clin Exp Metastasis       Date:  2009-05-15       Impact factor: 5.150

7.  Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and platelets.

Authors:  Sheng Zheng; Yan Liu; Yang Jiao; Min Wei; Xianlu Zeng
Journal:  Oncol Lett       Date:  2011-12-02       Impact factor: 2.967

8.  Surrogate markers of resectability in patients undergoing exploration of potentially resectable pancreatic adenocarcinoma.

Authors:  S L Ong; G Garcea; S C Thomasset; C D Mann; C P Neal; M Abu Amara; A R Dennison; D P Berry
Journal:  J Gastrointest Surg       Date:  2007-11-28       Impact factor: 3.452

9.  Evaluation of the prognostic value of platelet to lymphocyte ratio in patients with hepatocellular carcinoma.

Authors:  Yuchen Wang; Bashar M Attar; Harry E Fuentes; Palashkumar Jaiswal; Alfonso J Tafur
Journal:  J Gastrointest Oncol       Date:  2017-12

10.  The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?

Authors:  Shan Chen; Junbing Guo; Chongjin Feng; Zunfu Ke; Leihui Chen; Yunping Pan
Journal:  Ther Adv Med Oncol       Date:  2016-03-27       Impact factor: 8.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.